Last 12 months
Inside the activity.
1 purchase rows · 23 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 1 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2024 Filed May 30, 2024 23:41 UTC |
Perry James EEVP, CFO
|
GrantPerformance Rights · Derivative | 1,866 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000041 · wk-form4_1717112468.xml · derivative · entry 1 Perry James E · CIK 0001323684 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,866 Underlying: Common Stock · 1,866 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| May 29, 2024 Filed May 30, 2024 23:37 UTC |
Sullivan DonEVP, Chief Strategy Officer
|
GrantPerformance Rights · Derivative | 1,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000037 · wk-form4_1717112234.xml · derivative · entry 1 Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,790 Underlying: Common Stock · 1,790 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| May 28, 2024 Filed May 30, 2024 19:40 UTC |
Sweezey Jay KentDirector
|
GiftCommon Stock | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000040 · wk-form4_1717112417.xml · nonDerivative · entry 1 Sweezey Jay Kent · CIK 0001691674 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,326 F1 · kind: On May 28, 2024, the Reporting Person made a charitable gift of 40 shares to a nonprofit organization for which no payment or consideration was received by the Reporting Person. F1 · price: On May 28, 2024, the Reporting Person made a charitable gift of 40 shares to a nonprofit organization for which no payment or consideration was received by the Reporting Person. Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 18 | $235.23 | $4,234.14 |
DisclosureSEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 7 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,579 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F8 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.17 to $235.425, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 106 | $234.59 | $24,866.54 |
DisclosureSEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 6 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,597 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.17 to $235.165, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 101 | $233.62 | $23,595.62 |
DisclosureSEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 5 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,703 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.17 to $234.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 547 | $232.60 | $127,232.20 |
DisclosureSEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,804 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.155 to $233.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 180 | $231.79 | $41,722.20 |
DisclosureSEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,351 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.15 to $232.145, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 24 | $230.37 | $5,528.88 |
DisclosureSEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,531 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.925 to $230.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 17, 2024 Filed Apr 18, 2024 20:31 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 24 | $229.42 | $5,506.08 |
DisclosureSEC source: 0001624794-24-000020 · wk-form4_1713472280.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,555 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.80 to $229.755, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:28 UTC |
UNDERWOOD JEFFSVP, GM Contractor Solutions
|
Exercise / conversionPerformance Rights · Derivative | 1,553 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000019 · wk-form4_1712262510.xml · derivative · entry 4 UNDERWOOD JEFF · CIK 0002017190 · SVP, GM Contractor Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,553 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 30 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 30 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 30 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:28 UTC |
UNDERWOOD JEFFSVP, GM Contractor Solutions
|
Tax withholdingCommon Stock | 1,265 | $231.92 | $293,378.80 |
DisclosureSEC source: 0001624794-24-000019 · wk-form4_1712262510.xml · nonDerivative · entry 2 UNDERWOOD JEFF · CIK 0002017190 · SVP, GM Contractor Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,321 Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:28 UTC |
UNDERWOOD JEFFSVP, GM Contractor Solutions
|
Exercise / conversionCommon Stock | 3,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000019 · wk-form4_1712262510.xml · nonDerivative · entry 1 UNDERWOOD JEFF · CIK 0002017190 · SVP, GM Contractor Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:25 UTC |
Alverson LukeSVP, GC & Secretary
|
Exercise / conversionPerformance Rights · Derivative | 1,135 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000017 · wk-form4_1712262344.xml · derivative · entry 4 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,135 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:25 UTC |
Alverson LukeSVP, GC & Secretary
|
Tax withholdingCommon Stock | 927 | $231.92 | $214,989.84 |
DisclosureSEC source: 0001624794-24-000017 · wk-form4_1712262344.xml · nonDerivative · entry 2 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,307 Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:25 UTC |
Alverson LukeSVP, GC & Secretary
|
Exercise / conversionCommon Stock | 2,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000017 · wk-form4_1712262344.xml · nonDerivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:24 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
Exercise / conversionPerformance Rights · Derivative | 6,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000016 · wk-form4_1712262285.xml · derivative · entry 5 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,154 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 97 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 97 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 97 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:24 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
Tax withholdingCommon Stock | 4,920 | $231.92 | $1,141,046.40 |
DisclosureSEC source: 0001624794-24-000016 · wk-form4_1712262285.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,579 Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:24 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 12,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000016 · wk-form4_1712262285.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:27 UTC |
Perry James EEVP, CFO
|
Exercise / conversionPerformance Rights · Derivative | 2,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000018 · wk-form4_1712262429.xml · derivative · entry 4 Perry James E · CIK 0001323684 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,650 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 44 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 44 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 44 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:27 UTC |
Perry James EEVP, CFO
|
Tax withholdingCommon Stock | 2,131 | $231.92 | $494,221.52 |
DisclosureSEC source: 0001624794-24-000018 · wk-form4_1712262429.xml · nonDerivative · entry 2 Perry James E · CIK 0001323684 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,315 Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:27 UTC |
Perry James EEVP, CFO
|
Exercise / conversionCommon Stock | 5,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000018 · wk-form4_1712262429.xml · nonDerivative · entry 1 Perry James E · CIK 0001323684 · EVP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:23 UTC |
Sullivan DonEVP, GM Contractor Solutions
|
Exercise / conversionPerformance Rights · Derivative | 3,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000015 · wk-form4_1712262178.xml · derivative · entry 4 Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,029 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 53 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 53 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2024 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 53 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms. Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:23 UTC |
Sullivan DonEVP, GM Contractor Solutions
|
Tax withholdingCommon Stock | 2,435 | $231.92 | $564,725.20 |
DisclosureSEC source: 0001624794-24-000015 · wk-form4_1712262178.xml · nonDerivative · entry 2 Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,685 Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 20:23 UTC |
Sullivan DonEVP, GM Contractor Solutions
|
Exercise / conversionCommon Stock | 6,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000015 · wk-form4_1712262178.xml · nonDerivative · entry 1 Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:16 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,000 | $230.06 | $230,056.60 |
DisclosureSEC source: 0001624794-24-000013 · wk-form4_1710796599.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,997 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 22:07 UTC |
Sullivan DonEVP, GM Contractor Solutions
|
SaleCommon Stock | 2,029 | $231.59 | $469,896.11 |
DisclosureSEC source: 0001624794-24-000012 · wk-form4_1710540451.xml · nonDerivative · entry 2 Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,956 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.31 to $231.895, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 22:07 UTC |
Sullivan DonEVP, GM Contractor Solutions
|
SaleCommon Stock | 5,797 | $230.66 | $1,337,136.02 |
DisclosureSEC source: 0001624794-24-000012 · wk-form4_1710540451.xml · nonDerivative · entry 1 Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,985 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.29 to $231.26, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 21:42 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 263 | $233.30 | $61,357.90 |
DisclosureSEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 7 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,997 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F8 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.22 to $233.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 21:42 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 592 | $232.54 | $137,663.68 |
DisclosureSEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 6 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,260 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.21 to $233.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 21:42 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 47 | $231.73 | $10,891.31 |
DisclosureSEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 5 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,852 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.15 to $232.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 21:42 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 28 | $230.59 | $6,456.52 |
DisclosureSEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,899 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.135 to $231.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 21:42 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 31 | $229.37 | $7,110.47 |
DisclosureSEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,927 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.12 to $229.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 21:42 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 25 | $228.07 | $5,701.75 |
DisclosureSEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,958 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.80 to $228.46, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 21:42 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 14 | $227.21 | $3,180.94 |
DisclosureSEC source: 0001624794-24-000011 · wk-form4_1708551712.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,983 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 17, 2023. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.79 to $227.61, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 07, 2024 Filed Feb 7, 2024 21:50 UTC |
Alverson LukeSVP, GC & Secretary
|
GiftCommon Stock | 433 | $0.00 | $0.00 |
DisclosureSEC source: 0001624794-24-000010 · wk-form4_1707342627.xml · nonDerivative · entry 1 Alverson Luke · CIK 0001668461 · SVP, GC & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,916 F1 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 22:35 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 43 | $204.55 | $8,795.65 |
DisclosureSEC source: 0001624794-23-000107 · wk-form4_1702938894.xml · nonDerivative · entry 6 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,997 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.30 to $205.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 22:35 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 441 | $203.76 | $89,858.16 |
DisclosureSEC source: 0001624794-23-000107 · wk-form4_1702938894.xml · nonDerivative · entry 5 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,040 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.28 to $204.27, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 22:35 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 200 | $202.74 | $40,548.00 |
DisclosureSEC source: 0001624794-23-000107 · wk-form4_1702938894.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,481 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.27 to $203.26, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 22:35 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 173 | $201.82 | $34,914.86 |
DisclosureSEC source: 0001624794-23-000107 · wk-form4_1702938894.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,681 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.25 to $202.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 22:35 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 117 | $200.68 | $23,479.56 |
DisclosureSEC source: 0001624794-23-000107 · wk-form4_1702938894.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,854 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.23 to $201.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 22:35 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 26 | $199.85 | $5,196.10 |
DisclosureSEC source: 0001624794-23-000107 · wk-form4_1702938894.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,971 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.20 to $200.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:12 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 34 | $180.44 | $6,134.96 |
DisclosureSEC source: 0001624794-23-000106 · wk-form4_1700255517.xml · nonDerivative · entry 6 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,997 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.27 to $180.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:12 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 99 | $179.80 | $17,800.20 |
DisclosureSEC source: 0001624794-23-000106 · wk-form4_1700255517.xml · nonDerivative · entry 5 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,031 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.27 to $180.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:12 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 104 | $178.64 | $18,578.56 |
DisclosureSEC source: 0001624794-23-000106 · wk-form4_1700255517.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,130 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.19 to $179.11, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:12 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 122 | $177.18 | $21,615.96 |
DisclosureSEC source: 0001624794-23-000106 · wk-form4_1700255517.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,234 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.09 to $178.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:12 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 25 | $175.42 | $4,385.50 |
DisclosureSEC source: 0001624794-23-000106 · wk-form4_1700255517.xml · nonDerivative · entry 2 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,356 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.00 to $175.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:12 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 616 | $174.69 | $107,609.04 |
DisclosureSEC source: 0001624794-23-000106 · wk-form4_1700255517.xml · nonDerivative · entry 1 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,381 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.00 to $174.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 16, 2023 Filed Oct 16, 2023 21:20 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 93 | $176.91 | $16,452.63 |
DisclosureSEC source: 0001624794-23-000096 · wk-form4_1697491247.xml · nonDerivative · entry 4 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,997 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.50 to $177.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 16, 2023 Filed Oct 16, 2023 21:20 UTC |
Armes Joseph BDirector · Chairman, President & CEO
|
SaleCommon Stock | 92 | $176.05 | $16,196.60 |
DisclosureSEC source: 0001624794-23-000096 · wk-form4_1697491247.xml · nonDerivative · entry 3 Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,090 F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on December 12, 2022. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.50 to $176.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.